ArticleFrontiers in immunology2024

Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report.

Federica Giannotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.